Chison Medical Technologies Co., Ltd. (688358.SS)
CNY 28.01
(-0.46%)
CNY 28.01
(-0.46%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 6.31 Million CNY | 8.91% |
| 2022 | 5.79 Million CNY | 638.22% |
| 2021 | 785.56 Thousand CNY | -39.02% |
| 2020 | 1.28 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 4.32 Million CNY | 0.0% |
| 2024 Q3 | - CNY | 0.0% |
| 2024 Q1 | 5.55 Million CNY | 0.0% |
| 2023 Q4 | 6.31 Million CNY | 63.13% |
| 2023 FY | 6.31 Million CNY | 8.91% |
| 2023 Q3 | 3.87 Million CNY | -34.47% |
| 2023 Q2 | 5.9 Million CNY | 52.41% |
| 2023 Q1 | 3.87 Million CNY | -33.15% |
| 2022 Q4 | 5.79 Million CNY | 2358.39% |
| 2022 Q3 | 235.89 Thousand CNY | -39.3% |
| 2022 Q2 | 388.6 Thousand CNY | -38.93% |
| 2022 Q1 | 636.29 Thousand CNY | -19.0% |
| 2022 FY | 5.79 Million CNY | 638.22% |
| 2021 FY | 785.56 Thousand CNY | -39.02% |
| 2021 Q1 | - CNY | 0.0% |
| 2021 Q4 | 785.56 Thousand CNY | 25.6% |
| 2021 Q3 | 625.46 Thousand CNY | -14.01% |
| 2021 Q2 | 727.4 Thousand CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | 1.28 Million CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Shenzhen Lifotronic Technology Co., Ltd. | 2.49 Million CNY | -153.062% |